CNO Financial Group, Inc.
CNO
$40.05
$1.263.25%
Weiss Ratings | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Excellent | |||
Risk Index | Fair | |||
Risk Grade | C+ | |||
Reward Grade | A- | |||
Rating Factors | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Fair | |||
Growth Index | Excellent | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Good | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.05 | |||
Price History | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -1.30% | |||
30-Day Total Return | 0.18% | |||
60-Day Total Return | 5.73% | |||
90-Day Total Return | 16.92% | |||
Year to Date Total Return | 8.27% | |||
1-Year Total Return | 54.45% | |||
2-Year Total Return | 87.64% | |||
3-Year Total Return | 81.73% | |||
5-Year Total Return | 332.55% | |||
52-Week High % Change | -8.54% | |||
52-Week Low % Change | 55.66% | |||
Price | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $42.41 | |||
52-Week Low Price | $24.92 | |||
52-Week Low Price (Date) | Apr 11, 2024 | |||
52-Week High Price (Date) | Mar 03, 2025 | |||
Valuation | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 3.91B | |||
Enterprise Value | 6.87B | |||
Price/Earnings (TTM) | 10.37 | |||
Earnings Per Share (TTM) | 3.74 | |||
Earnings Per Share Growth | 55.55% | |||
Price/Earnings To Growth | 0.19 | |||
Price/Sales (TTM) | 0.92 | |||
Price/Book (Q) | 1.58 | |||
Enterprise Value/Revenue (TTM) | 1.54 | |||
Price | $40.05 | |||
Enterprise Value/EBITDA (TTM) | 6.45 | |||
Enterprise Value/EBIT | 8.90 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 105.23M | |||
Dividend Yield | 1.65% | |||
Div. Per Share (Most Recent) | $0.16 | |||
Dividend Per Share (TTM) | $0.64 | |||
Payout Ratio (TTM) | 16.76% | |||
Dividend Per Share (Most Recent) | $0.16 | |||
Company Info | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 317 817 6100 | |||
Address | 11299 Illinois Street Carmel, IN 46032 | |||
Website | www.cnoinc.com | |||
Country | United States | |||
Year Founded | 1979 | |||
Profitability | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 17.36% | |||
Profit Margin | 9.07% | |||
Management Effectiveness | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 1.33% | |||
Return on Equity | 17.14% | |||
Income Statement | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 4.31B | |||
Total Revenue (TTM) | 4.45B | |||
Revenue Per Share | $42.28 | |||
Gross Profit (TTM) | 1.83B | |||
EBITDA (TTM) | 1.07B | |||
EBIT (TTM) | 772.70M | |||
Net Income (TTM) | 404.00M | |||
Net Income Avl. to Common (TTM) | 404.00M | |||
Total Revenue Growth (Q YOY) | -6.26% | |||
Earnings Growth (Q YOY) | 357.58% | |||
EPS Diluted (TTM) | 3.74 | |||
EPS Diluted Growth (Q YOY) | 402.19% | |||
Balance Sheet | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.96B | |||
Cash Per Share (Q) | $18.63 | |||
Total Current Assets (Q) | 6.75B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 2.50B | |||
Current Ratio (Q) | 3.427 | |||
Book Value Per Share (Q) | $24.59 | |||
Total Assets (Q) | 37.85B | |||
Total Current Liabilities (Q) | 1.97B | |||
Total Debt (Q) | 4.62B | |||
Total Liabilities (Q) | 35.35B | |||
Total Common Equity (Q) | 2.50B | |||
Cash Flow | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -1.49B | |||
Cash from Financing (TTM) | 1.97B | |||
Net Change in Cash (TTM) | 1.11B | |||
Levered Free Cash Flow (TTM) | 537.04M | |||
Cash from Operations (TTM) | 627.70M | |||